Novel P143L polymorphism of the LCAT gene is associated with dyslipidemia in Chinese patients who have coronary atherosclerotic heart disease

Biochemical and Biophysical Research Communications

Volumn 318, Issue 1, 2004, Pages 4-10

  Zhang, Kelan ^a,b,c   Zhang, Sizhong ^a,b   Zheng, Keqin ^a,b   Hou, Yiping ^d   Liao, Linchuan ^d   He, Yong ^a   Zhang, Li ^a   Nebert, Daniel W ^e   Shi, Jiajun ^a,b   Su, Zhiguang ^a,b   Xiao, Cuiying ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Red Cross Hospital of Yunnan Province   (China)

^d SICHUAN UNIVERSITY   (China)

^e UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Coronary atherosclerotic heart disease; DHPLC; Dyslipidemia; LCAT gene; P143L polymorphism

Indexed keywords

PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ADULT; AGE; ARTICLE; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DENATURATION; DYSLIPIDEMIA; EXON; FEMALE; GENDER; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEART DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY ARTERIOSCLEROSIS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 11144354758     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.177     Document Type: Article

References (22)

1. Lusis A.J. Atherosclerosis. Nature. 407:2000;233-241.
2. Stephens J.W., Humphries S.E. The molecular genetics of cardiovascular disease: clinical implications. J. Intern. Med. 253:2003;120-127.
3. Fielding C.J. Lecithin: cholesterol acyltransferase. Esfahani M., Swaney J. Advances in Cholesterol Research. 1990;270-314 Telford Press, Caldwell, NJ.
4. Francone O.L., Gurakar A., Fielding C.J. Distribution and function of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. J. Biol. Chem. 264:1989;7066-7072.
5. Peelman F., Vandekerckhove J., Rosseneu M. Structure and function of lecithin cholesterol acyl transferase: new insights from structural predictions and animal models. Curr. Opin. Lipidol. 11:2000;155-160.
6. Miller N.E., Rajput-Williams J., Nanjee M.N., Samuel L., Albers J.J. Relationship of high-density lipoprotein composition to plasma lecithin-cholesterol acyltransferase concentration in men. Atherosclerosis. 69:1988;123-129.
7. Santamarina-Fojo S., Lambert G., Hoeg J.M., Brewer H.B. Jr. Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis. Curr. Opin. Lipidol. 11:2000;267-275.
8. Kuivenhoven J.A., Pritchard H., Hill J., Frohlich J., Assmann G., Kastelein J. The molecular pathology of lecithin: cholesterol acyltransferase (LCAT) deficiency syndromes. J. Lipid Res. 38:1997;191-205.
9. Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., Lander E.S. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 22:1999;231-238.
10. Recalde D., Cenarro A., Civeira F., Garcia-Otin A.F., Pocovi M. A novel DNA polymorphism (4886C. > T) in the human LCAT gene Hum. Mutat. 15:2000;298-299.
11. Su Z.G., Zhang S.Z., Hou Y.P., Li T., Nebert D.W., Zhang L., Huang D.J., Liao L.C., Xiao C.Y. Single-nucleotide polymorphisms in the lipoprotein lipase gene associated with coronary heart disease in Chinese. Eur. J. Pharmacol. 454:2002;9-18.
12. Su Z., Zhang S., Nebert D.W., Zhang L., Huang D., Hou Y., Liao L., Xiao C. A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity. J. Lipid Res. 43:2002;1595-1601.
13. Jonas A. Lecithin cholesterol acyltransferase. Biochim. Biophys. Acta. 1529:2000;245-256.
14. Castelli W., Doyle J., Gordon T., Hames C.G., Hjortland M.C., Hulley S.B., Kagan A., Zukel W.J. HDL cholesterol and other lipids in coronary heart disease. Circulation. 55:1977;767-772.
15. Hoeg J.M., Santamarina-Fojo S., Berard A.M., Cornhill J.F., Herderick E.E., Feldman S.H., Haudenschild C.C., Vaisman B.L., Hoyt R.F. Jr., Demosky S.J. Jr., Kauffman R.D., Hazel C.M., Marcovina S.M., Brewer H.B. Jr. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc. Natl. Acad. Sci. USA. 93:1996;1448-1453.
16. Hoeg J.M., Vaisman B.L., Demosky S.J. Jr., Meyn S.M., Talley G.D., Hoyt R.F. Jr., Feldman S., Berard A.M., Sakai N., Wood D., Brousseau M.E., Marcovina S., Brewer H.B. Jr., Santamarina-Fojo S. Lecithin:cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits. J. Biol. Chem. 271:1996;4396-4402.
17. Francone O.L., Gong E.L., Ng D.S., Fielding C.J., Rubin E.M. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism. J. Clin. Invest. 96:1995;1440-1448.
18. Miettinen H.E., Gylling H., Tenhunen J., Virtamo J., Jauhiainen M., Huttunen J.K., Kantola I., Miettinen T.A., Kontula K. A novel Gly230Arg mutation (LCATFin) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 18:1998;591-598.
19. Kuivenhoven J.A., Stalenhoef A.F., Hill J.S., Demacker P.N., Errami A., Kastelein J.J., Pritchard P.H. Two novel molecular defects in the LCAT gene are associated with fish eye disease. Arterioscler. Thromb. Vasc. Biol. 16:1996;294-303.
20. Funke H., von Eckardstein A., Pritchard P.H., Albers J.J., Kastelein J.J., Droste C., Assmann G. A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity. Proc. Natl. Acad. Sci. USA. 88:1991;4855-4859.
21. Kuivenhoven J.A., van Voorst tot Voorst E.J., Wiebusch H., Marcovina S.M., Funke H., Assmann G., Pritchard P.H., Kastelein J.J. A unique genetic and biochemical presentation of fish-eye disease. J. Clin. Invest. 96:1995;2783-2791.
22. Klein H.G., Duverger N., Albers J.J., Marcovina S., Brewer H.B. Jr., Santamarina-Fojo S. In vitro expression of structural defects in the lecithin-cholesterol acyltransferase gene. J. Biol. Chem. 270:1995;9443-9447.